Our clinical trial experts dive into three topics that will help get you started on the right path to a successful trial.
With Premier Research, every aspect of your clinical trial, from design and investigators to sites and patient selection are customized for your indication – including preferential regulatory pathways and other strategies for successful early planning and engagement. Register for our webinar series to explore pathways to ensure better outcomes for your clinical trials.
Part 1: Considerations to Improve Patient Outcomes in Early Drug Development
Thursday, February 17 | 10am EST / 4pm GMT / 5pm CET
When preparing for expedited drug development, you need to understand the steps that comprise a successful first-in-human study. This webinar will show you where to start, describe pathways for accelerated development, and equip you to effectively engage with regulators.
Part 2: Empowering Oncology Patients to Maximize Study Outcomes: Strategies and Considerations for Sponsors
Thursday, February 24 | 10am EST / 4pm GMT / 5pm CET
This webinar discusses the benefits of smart study design, including greater patient engagement, improved trial outcomes, and better-targeted dosing. Many modern clinical trials, especially in oncology, involve long-term follow-up. Engaging and supporting patients early in the study process keeps them enrolled and leads to a fuller understanding of their treatment and their emotional journey.
Part 3: Alternative Designs to the Traditional 3+3 Design in Phase 1 Dose-Escalation Studies
Thursday, March 3 | 10am EST / 4pm GMT / 5pm CET
Following up from the last webinar, additional benefits of smart study design are better-targeted dosing, greater patient engagement, and improved trial outcomes. Phase 2 trials often fail because patients are given a sub-therapeutic dose. Explore this issue, its broader implications, and alternate Bayesian model-based dose-escalation designs.